Biflavonoid Methylchamaejasmin and Khaya grandifoliola Extract Inhibit NLRP3 Inflammasome in THP-1 Cell Model of Neuroinflammation
Authors:
- Brice Ayissi OwonaBOBrice Ayissi Owona
- Arnaud MaryAMArnaud Mary
- Angelique N. MessiAMAngelique N. Messi
- Kishore Aravind RavichandranKRKishore Aravind Ravichandran
- Josephine Ngo MbingJMJosephine Ngo Mbing
- Emmanuel PegnyembEPEmmanuel Pegnyemb
- Paul F. MoundipaPMPaul F. Moundipa
- Michael T. HenekaMHMichael T. Heneka
- 16 July 2024
- journal article
- research article
- Published by Springer Nature in Molecular Neurobiology
- Vol. 62 (2) , 1605-1619
Abstract
Neuroinflammation is a common hallmark of Alzheimer’s disease (AD), with NLRP3 inflammasome proven to be activated in microglia of AD patients’ brains. In this study, a newly isolated biflavonoid (7,7′-di-O-methylchamaejasmin/M8) and a crude extract of the plant Khaya grandifoliola (KG) were investigated for their inhibitory effect on inflammasome activation. In preliminary experiments, M8 and KG showed no cytotoxicity on human macrophage-like differentiated THP-1 cells and exhibited anti-inflammatory inhibition of nitric oxide produced following lipopolysaccharide stimulation. Furthermore, M8 and KG blocked IL-1β and IL-18 production by reducing NLRP3 inflammasome components including NFκB, NLRP3, Caspase-1, pro-IL-1β, and pro-IL-18 at the mRNA and protein levels. Regarding the formation of ASC (apoptosis-associated speck-like protein containing a CARD) specks during inflammasome activation, the size and fluorescent intensity of the existing specks were unchanged across all treatment conditions. However, M8 and KG treatments were shown to prevent further speck formation. In addition, experiments on amyloid β phagocytosis showed that M8 and KG pretreatments can restore the phagocytic activity of THP-1 cells, which was impaired following inflammasome activation. Altogether, our findings describe for the first time a promising role of biflavonoids and KG extract in preventing inflammasome activation and protecting against neuroinflammation, a key factor in AD development.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (HE3350/19-1)
This publication has 45 references indexed in Scilit:
- Khaya grandifoliola active fraction as a source of therapeutic compounds for Alzheimer’s disease treatment: In silico validation of identified compoundsIn Silico Pharmacology, 2022
- Potential of flavonoids as anti-Alzheimer’s agents: bench to bedsideEnvironmental Science and Pollution Research, 2022
- Oridonin attenuates carrageenan-induced pleurisy via activation of the KEAP-1/Nrf2 pathway and inhibition of the TXNIP/NLRP3 and NF-κB pathway in miceInflammopharmacology, 2019
- Khaya grandifoliola C.DC: a potential source of active ingredients against hepatitis C virus in vitroArchives of Virology, 2016
- Antioxidant fractions of Khaya grandifoliola C.DC. and Entada africana Guill. et Perr. induce nuclear translocation of Nrf2 in HC-04 cellsCell Stress and Chaperones, 2015
- Acyl flavonoids, biflavones, and flavonoids from Cephalotaxus harringtonia var. nanaJournal of Natural Medicines, 2015
- Biflavonoids as Potential Small Molecule Therapeutics for Alzheimer’s Disease2015
- A Review on Pharmacological and Analytical Aspects of NaringeninChinese Journal of Integrative Medicine, 2014
- Expression of the NLRP3 Inflammasome in Cerebral Cortex After Traumatic Brain Injury in a Rat ModelNeurochemical Research, 2013
- ASC Speck Formation as a Readout for Inflammasome Activation2013